SOTERA HEALTH COMPANY (SHC) Gross Margin
- Gross margin · 12 months: Value 54.97%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 54.97% | Gross profit / revenue. Period ending 2026-06-30. $668.51M ÷ $1.22B × 100 ≈ 54.97% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 668.51M USD | Gross Profit |
| Revenue | 1.22B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $668.51M | $1.22B | (m) | 54.97% |
| 2026-03-31 | $657.17M | $1.19B | (m) | 55.26% |
| 2025-12-31 | $645.53M | $1.16B | (m) | 55.48% |
| 2025-09-30 | $643.98M | $1.15B | (m) | 55.98% |
| 2025-06-30 | $624.44M | $1.12B | (m) | 55.53% |
| 2025-03-31 | $610.61M | $1.11B | (m) | 55.17% |
| 2024-12-31 | $602.29M | $1.10B | (m) | 54.73% |
| 2024-09-30 | $618.01M | $1.12B | (m) | 55.16% |
| 2024-06-30 | $605.97M | $1.10B | (m) | 55.18% |
| 2024-03-31 | $592.77M | $1.08B | (m) | 55.05% |
| 2023-12-31 | $577.16M | $1.05B | (m) | 55.00% |
| 2023-09-30 | $538.79M | $990.64M | (m) | 54.39% |
| 2023-06-30 | $528.82M | $976.17M | (m) | 54.17% |
| 2023-03-31 | $539.63M | $987.52M | (m) | 54.65% |
| 2022-12-31 | $557.00M | $1.00B | (m) | 55.50% |
| 2022-09-30 | $549.24M | $993.35M | (m) | 55.29% |
| 2022-06-30 | $538.81M | $970.81M | (m) | 55.50% |
| 2022-03-31 | $532.17M | $956.08M | (m) | 55.66% |
| 2021-12-31 | $518.67M | $931.48M | (m) | 55.68% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $443.57M | $818.16M | (m) | 54.22% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
| 2019-12-31 | $395.43M | $778.33M | (m) | 50.81% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |